Seattle, WA – According to filings with the U.S. Securities and Exchange Commission, Bardy Diagnostics is raising $13,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Gust Bardy played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Bardy Diagnostics

Bardy Diagnostics, Inc. has created a new, state-of-the-art heart monitor known as Carnation Ambulatory Monitor (CAM) that can be worn comfortably and discreetly for up to 7 days. Unlike many other heart monitors, CAM can be worn during exercise or while showering. Its unique, narrow, hourglass shape makes it especially advantageous for the female anatomy. Developed on the principle that non-invasive cardiac monitoring should provide an excellent quality atrial signal, the CAM is designed to be placed along the sternum over the heart to optimize P-wave signal capture. The result is improved ECG resolution, providing more information about the heart rhythm which may lead to more clinically actionable diagnoses.

To learn more about Bardy Diagnostics, visit http://www.bardydx.com/

Contact:
Gust Bardy, Chief Executive Officer
844-777-9283
bardyg@bardydx.com

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved